Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-oh Han, Dwight D. Koeberl, Christian Leborgne et al.|Molecular Therapy — Methods & Clinical Development|2017Cited by 77
Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-oh Han, Dwight D. Koeberl, Giuseppe Ronzitti et al.|Molecular Therapy — Methods & Clinical Development|2019Cited by 6
Minimum effective dose for immune tolerance induction with an adendo-associated virus vector in Pompe diseaseSang-oh Han, Dwight D. Koeberl, Marshall E. Lewis et al.|Molecular Genetics and Metabolism|2016Cited by 0
49. Minimum Effective Dose of Liver-Targeted Gene Therapy for Pompe Disease Reduced 10-Fold from Prior EstimatesSang-oh Han, Dwight D. Koeberl, Federico Mingozzi et al.|Molecular Therapy|2016Cited by 0